(Circulation. 1995;91:1824-1833.)
© 1995 American Heart Association, Inc.
Articles |
Enalapril Treatment Increases Cardiac Performance and Energy Reserve Via the Creatine Kinase Reaction in Myocardium of Syrian Myopathic Hamsters With Advanced Heart Failure
Presented at the 66th Scientific Sessions of the American Heart Association, Atlanta, Ga, November 8-11, 1993.
From the NMR Laboratory for Physiological Chemistry, Department of Medicine, Brigham and Women's Hospital, Boston, Mass (L.N., J.F., J.S.I.); the Department of Medicine, Beth Israel Hospital, Boston, Mass (R.L.); and the Istituto di Medicina Clinica, Università di Padova, Italy (P.P., A.C.P.).
Correspondence to Joanne S. Ingwall, PhD, NMR Laboratory for Physiological Chemistry, Department of Medicine, Brigham and Women's Hospital, 221 Longwood Ave, Room 209, Boston, MA 02115.
Background Converting enzyme inhibitor treatment of congestive heart failure slows progression to failure and reduces mortality rate. It is not known whether these benefits are due solely to improved hemodynamics or also to improved myocyte energetics. This study examines the effect of enalapril treatment on both isovolumic contractile performance and its biochemical correlate, flux through the creatine kinase (CK) system, in an animal model of severely failing myocardium.
Methods and Results Seven-month-old Syrian cardiomyopathic (TO-2 strain) and normal golden Syrian (FIB strain) hamsters were each randomly assigned to one of three groups supplied daily with either no, low (25 mg/kg body wt), or high (100 mg/kg body wt) doses of enalapril for 12 to 14 weeks. At 10 months of age, all substrates and products and flux through the CK reaction were measured in isolated perfused hearts by 31P magnetization transfer and chemical assay. Compared with normal hamsters, the myopathic hamsters exhibited significantly lower body weights and higher biventricular heart weights, which were partially reversed by drug treatment. The Langendorff-perfused hearts showed decreased isovolumic contractile performance with identical load conditions. This was partially reversed by drug treatment. In the failing hearts, the following substrate and product concentrations and enzyme activities were decreased compared with nonfailing hearts but were unchanged by drug treatment: ATP (-28%), phosphocreatine (-48%), free creatine (-64%), ADP (-51%), and CK (-34%, primarily MM isoenzyme). Flux through the CK reaction for the untreated cardiomyopathic hamster hearts was decreased by 67%, and this decrease was almost completely reversed by enalapril treatment. The increased CK flux is due to an increase in the rate constant for the reaction, since substrate concentrations are unchanged, and is not predicted by the rate equation. In enalapril-treated failing hearts, phosphoryl transfer via the CK reaction increased with contractile performance. This was not observed in the nonfailing hearts, in which energy reserve is adequate to support changes in contractile performance.
Conclusions Decreased flux through CK reaction leads to decreased capacity for ATP synthesis and may contribute to decreased contractile performance in cardiomyopathic hamster hearts. Enalapril treatment results in increased phosphoryl transfer through the CK reaction in failing myocardium, and this increase is coupled to improved cardiac performance. Decreased CK flux in failing hearts is due to a combination of decreased Vmax and lower guanidino pool; this mechanism fails to explain changes in CK flux in enalapril-treated failing hearts.
Key Words: cardiomyopathy • enalapril • creatine kinase • spectroscopy
This article has been cited by other articles:
 |
|
 |
|
  O. J. Kemi, M. A. Hoydal, P. M. Haram, A. Garnier, D. Fortin, R. Ventura-Clapier, and O. Ellingsen Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan Cardiovasc Res, October 1, 2007; 76(1): 91 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Neubauer The Failing Heart -- An Engine Out of Fuel N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151. [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Cha, P. P. Dzeja, M. M. Redfield, W. K. Shen, and A. Terzic Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1686 - H1692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wallis, C. A. Lygate, A. Fischer, M. ten Hove, J. E. Schneider, L. Sebag-Montefiore, D. Dawson, K. Hulbert, W. Zhang, M. H. Zhang, et al. Supranormal Myocardial Creatine and Phosphocreatine Concentrations Lead to Cardiac Hypertrophy and Heart Failure: Insights From Creatine Transporter-Overexpressing Transgenic Mice Circulation, November 15, 2005; 112(20): 3131 - 3139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Armoni, C. Harel, F. Bar-Yoseph, S. Milo, and E. Karnieli Free Fatty Acids Repress the GLUT4 Gene Expression in Cardiac Muscle via Novel Response Elements J. Biol. Chem., October 14, 2005; 280(41): 34786 - 34795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nahrendorf, M. Spindler, K. Hu, L. Bauer, O. Ritter, P. Nordbeck, T. Quaschning, K.-H. Hiller, J. Wallis, G. Ertl, et al. Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction Cardiovasc Res, February 1, 2005; 65(2): 419 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Weiss, G. Gerstenblith, and P. A. Bottomley ATP flux through creatine kinase in the normal, stressed, and failing human heart PNAS, January 18, 2005; 102(3): 808 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Ingwall and R. G. Weiss Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function Circ. Res., July 23, 2004; 95(2): 135 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bahi, N. Koulmann, H. Sanchez, I. Momken, V. Veksler, A. X. Bigard, and R. Ventura-Clapier Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol, January 1, 2004; 96(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Park, J. Zhang, Y. Ye, S. Ormaza, P. Liang, A. J. Bank, L. W. Miller, and R. J. Bache Myocardial creatine kinase expression after left ventricular assist device support J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1773 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Horn, H. Remkes, H. Stromer, C. Dienesch, and S. Neubauer Chronic Phosphocreatine Depletion by the Creatine Analogue {beta}-Guanidinopropionate Is Associated With Increased Mortality and Loss of ATP in Rats After Myocardial Infarction Circulation, October 9, 2001; 104(15): 1844 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hugel, M. Horn, M. de Groot, H. Remkes, C. Dienesch, K. Hu, G. Ertl, and S. Neubauer Effects of ACE inhibition and beta -receptor blockade on energy metabolism in rats postmyocardial infarction Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2167 - H2175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shen, K. Asai, M. Uechi, M. A. Mathier, R. P. Shannon, S. F. Vatner, and J. S. Ingwall Progressive Loss of Myocardial ATP Due to a Loss of Total Purines During the Development of Heart Failure in Dogs : A Compensatory Role for the Parallel Loss of Creatine Circulation, November 16, 1999; 100(20): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mateo, V. Stepanov, B. Gillet, J.-C. Beloeil, and J. A. Hoerter Cardiac performance and creatine kinase flux during inhibition of ATP synthesis in the perfused rat heart Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H308 - H317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Horn, H. Remkes, C. Dienesch, K. Hu, G. Ertl, and S. Neubauer Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction Cardiovasc Res, July 1, 1999; 43(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Dzeja, K. T. Vitkevicius, M. M. Redfield, J. C. Burnett, and A. Terzic Adenylate Kinase–Catalyzed Phosphotransfer in the Myocardium : Increased Contribution in Heart Failure Circ. Res., May 28, 1999; 84(10): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Neubauer, M. Horn, M. Cramer, K. Harre, J. B. Newell, W. Peters, T. Pabst, G. Ertl, D. Hahn, J. S. Ingwall, et al. Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy Circulation, October 7, 1997; 96(7): 2190 - 2196. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. Stepanov, P. Mateo, B. Gillet, J. C. Beloeil, P. Lechene, and J. A. Hoerter Kinetics of creatine kinase in an experimental model of low phosphocreatine and ATP in the normoxic heart Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1397 - C1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tian, L. Nascimben, J. S. Ingwall, and B. H. Lorell Failure to Maintain a Low ADP Concentration Impairs Diastolic Function in Hypertrophied Rat Hearts Circulation, August 19, 1997; 96(4): 1313 - 1319. [Abstract] [Full Text]
|
|
|
|
|
|
M. Guazzi, G. Marenzi, M. Alimento, M. Contini, and P. Agostoni Improvement of Alveolar–Capillary Membrane Diffusing Capacity With Enalapril in Chronic Heart Failure and Counteracting Effect of Aspirin Circulation, April 1, 1997; 95(7): 1930 - 1936. [Abstract] [Full Text]
|
|
|
|
|
|
G. Hasenfuss, L. A. Mulieri, P. D. Allen, H. Just, and N.R. Alpert Influence of Isoproterenol and Ouabain on Excitation-Contraction Coupling, Cross-Bridge Function, and Energetics in Failing Human Myocardium Circulation, December 15, 1996; 94(12): 3155 - 3160. [Abstract] [Full Text]
|
|
|
|
|
|
L. Nascimben, J. S. Ingwall, P. Pauletto, J. Friedrich, J. K. Gwathmey, V. Saks, A. C. Pessina, and P.D. Allen Creatine Kinase System in Failing and Nonfailing Human Myocardium Circulation, October 15, 1996; 94(8): 1894 - 1901. [Abstract] [Full Text]
|
|
|
|
|
|
R. Liao, L. Nascimben, J. Friedrich, J. K. Gwathmey, and J. S. Ingwall Decreased Energy Reserve in an Animal Model of Dilated Cardiomyopathy : Relationship to Contractile Performance Circ. Res., May 1, 1996; 78(5): 893 - 902. [Abstract] [Full Text]
|
|
|
|
|
|
J. Friedrich, C. S. Apstein, and J. S. Ingwall 31P Nuclear Magnetic Resonance Spectroscopic Imaging of Regions of Remodeled Myocardium in the Infarcted Rat Heart Circulation, December 15, 1995; 92(12): 3527 - 3538. [Abstract] [Full Text]
|
|